Hyperkalemia associated with inhibitors of the renin-angiotensin-aldosterone System - Balancing risk and benefit

被引：26

作者：

Desai, Akshay ^{[1
]}

机构：

[1] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA

来源：

CIRCULATION | 2008年 / 118卷 / 16期

关键词：

editorials; aldosterone; drugs; heart failure; myocardial infarction; potassium;

D O I：

10.1161/CIRCULATIONAHA.108.807917

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1609 / 1611

页数：3

共 10 条

[1] Task force 1: The ACCF and AHA codes of conduct in human subjects research [J].

Adams, RJ ;

Antman, EM ;

Kavey, REW .

CIRCULATION, 2004, 110 (16) :2512-2516

[2] Complications of inappropriate use of spiroholactone in heart failure: When an old medicine spirals out of new guidelines [J].

Bozkurt, B ;

Agoston, I ;

Knowlton, AA .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (02) :211-214

[3] Incidence and predictors of hyperkalemia in patients with heart failure [J].

Desai, Akshay S. ;

Swedberg, Karl ;

McMurray, John V. ;

Granger, Christopher B. ;

Yusuf, Salim ;

Young, James B. ;

Dunlap, Mark E. ;

Solomon, Scott D. ;

Hainer, James W. ;

Olofsson, Bertil ;

Michelson, Eric L. ;

Pfeffer, Marc A. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (20) :1959-1966

[4] Rates of hyperkalemia after publication of the randomized aldactone evaluation study [J].

Juurlink, DN ;

Mamdani, MM ;

Lee, DS ;

Kopp, A ;

Austin, PC ;

Laupacis, A ;

Redelmeier, DA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (06) :543-551

[5] Treatment of heart failure with spironolactone - Trial and tribulations [J].

McMurray, JJV ;

O'Meara, E .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (06) :526-528

[6] Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system [J].

Palmer, BF .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (06) :585-592

[7] The effect of spironolactone on morbidity and mortality in patients with severe heart failure [J].

Pitt, B ;

Zannad, F ;

Remme, WJ ;

Cody, R ;

Castaigne, A ;

Perez, A ;

Palensky, J ;

Wittes, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) :709-717

[8] Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) [J].

Pitt, Bertram ;

Bakris, George ;

Ruilope, Luis M. ;

DiCarlo, Lorenzo ;

Mukherjee, Robin .

CIRCULATION, 2008, 118 (16) :1643-1650

[9] Renal considerations in angiotensin converting enzyme inhibitor therapy - A statement for healthcare professionals from the council on the kidney in cardiovascular disease and the council for high blood pressure research of the American Heart Association [J].

Schoolwerth, AC ;

Sica, DA ;

Ballermann, BJ ;

Wilcox, CS .

CIRCULATION, 2001, 104 (16) :1985-1991

[10] The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure [J].

Shah, KB ;

Rao, K ;

Sawyer, R ;

Gottlieb, SS .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (05) :845-849

← 1 →